Ji Xiaoyan, Jin Peng, Chu Yuejie, Feng Shuhong, Wang Penghua
1Tianjin Medical University, Tianjin, China.
Int J Low Extrem Wounds. 2014 Mar;13(1):64-71. doi: 10.1177/1534734614521236. Epub 2014 Feb 10.
The objective was to determine multidrug-resistant organisms' (MDROs) profile in diabetic foot ulcers (DFU), antibiotic resistance of MDROs, and to find the potential risk factors for infection with MDROs. In 157 patients with DFU admitted to Tianjin Metabolic Disease Hospital, China, from January 2011 to January 2012, microbiological specimens were taken on admission. The patients were divided into 2 groups according to the infection of MDROs. Potential risk factors for MDRO-positive specimens were examined using univariate and multivariate analyses. Seventy-eight MDRO strains were isolated from patients in the MDRO+ group, among which the top 3 were Staphylococcus aureus (16.7%), Enterobacter spp (16.7%), and Pseudomonas aeruginosa (15.4%). Most of the MDROs were resistant to at least 8 kinds of commonly used antibiotics. Gram-negative MDROs showed 23% to 50% resistance to third-generation cephalosporins. The resistant rates of Gram-positive MDROs to fluoroquinolone were more than 70%; penicillin and semisynthetic penicillin were 57% to 100% resistant. Previous hospitalization (odds ratio [OR] = 3.000; 95% confidence interval [CI] = 1.100-8.182; P = .032), previous duration of antibiotic therapy (OR = 1.078; 95% CI = 1.001-1.160; P = .046), ulcer type (OR = 7.185; 95% CI = 2.115-24.408; P = .002), ulcer size (OR = 1.403; 95% CI = 1.042-1.888; P = .026), and osteomyelitis (OR = 3.390; 95% CI = 1.178-9.756; P = .024) were associated with MDRO infection in patients with DFU.
目的是确定糖尿病足溃疡(DFU)中多重耐药菌(MDROs)的情况、MDROs的抗生素耐药性,并找出感染MDROs的潜在危险因素。2011年1月至2012年1月在中国天津代谢病医院收治的157例DFU患者,入院时采集微生物标本。根据是否感染MDROs将患者分为2组。使用单因素和多因素分析检查MDRO阳性标本的潜在危险因素。MDRO+组患者中分离出78株MDRO菌株,其中前三位是金黄色葡萄球菌(16.7%)、肠杆菌属(16.7%)和铜绿假单胞菌(15.4%)。大多数MDROs对至少8种常用抗生素耐药。革兰阴性MDROs对第三代头孢菌素的耐药率为23%至50%。革兰阳性MDROs对氟喹诺酮类的耐药率超过70%;对青霉素和半合成青霉素的耐药率为57%至100%。既往住院史(比值比[OR]=3.000;95%置信区间[CI]=1.100 - 8.182;P = 0.032)、既往抗生素治疗时长(OR = 1.078;95% CI = 1.001 - 1.160;P = 0.046)、溃疡类型(OR = 7.185;95% CI = 2.115 - 24.408;P = 0.002)、溃疡大小(OR = 1.403;95% CI = 1.042 - 1.888;P = 0.026)和骨髓炎(OR = 3.390;95% CI = 1.178 - 9.756;P = 0.024)与DFU患者的MDRO感染有关。